Makoto Kuro-o

Title: The Innovative Contributions of Makoto Kuro-o

Introduction

Makoto Kuro-o is a prominent inventor based in Dallas, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins. With a total of 5 patents to his name, Kuro-o's work has the potential to impact medical diagnostics and treatments.

Latest Patents

Kuro-o's latest patents include groundbreaking innovations such as antibodies that specifically bind to alpha klotho. This invention details an antibody and/or binding fragment that comprises a light chain variable region and a heavy chain variable region. The specific sequences of the complementarity determining regions (CDRs) are crucial for the antibody's function. Another notable patent involves nucleic acids encoding antibodies with high affinity for alpha klotho, which can be used to diagnose kidney diseases. These patents reflect Kuro-o's commitment to advancing medical science through innovative solutions.

Career Highlights

Throughout his career, Makoto Kuro-o has worked with esteemed institutions such as the University of Texas System and the University of Toronto. His research has focused on the development of therapeutic antibodies, showcasing his expertise in the field. Kuro-o's contributions have not only advanced scientific knowledge but have also paved the way for potential clinical applications.

Collaborations

Kuro-o has collaborated with notable colleagues, including Sachdev Singh Sidhu and Sarah L Barker. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Makoto Kuro-o's work exemplifies the spirit of innovation in biotechnology. His patents and collaborations highlight his dedication to improving healthcare through scientific advancements. The impact of his inventions is likely to resonate in the medical community for years to come.